CeriBell, Inc. Common Stock
CBLL
About: CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
Employees: 281
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
273% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 11
56% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 16
9% more funds holding
Funds holding: 86 [Q1] → 94 (+8) [Q2]
4.51% more ownership
Funds ownership: 67.17% [Q1] → 71.69% (+4.51%) [Q2]
5% more capital invested
Capital invested by funds: $463M [Q1] → $485M (+$22.2M) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 4 [Q1] → 4 (+0) [Q2]
Financial journalist opinion